BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30880498)

  • 1. Low P4HA2 and high PRTN3 expression predicts poor survival in patients with pancreatic cancer.
    Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
    Scand J Gastroenterol; 2019 Feb; 54(2):246-251. PubMed ID: 30880498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
    Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
    BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis.
    Lu XH; Sang D; Zhang YR; Yuan Q
    Clinics (Sao Paulo); 2022; 77():100123. PubMed ID: 36403427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma.
    Hu D; Ansari D; Zhou Q; Sasor A; Hilmersson KS; Bauden M; Jiang Y; Andersson R
    BMC Cancer; 2018 Nov; 18(1):1096. PubMed ID: 30419838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolyl-4-Hydroxylase α Subunit 2 as a Novel Potential Biomarker for Predicting the Prognosis of Epithelial Ovarian Carcinoma.
    Zhang H; Zhao W
    Cancer Manag Res; 2021; 13():4455-4462. PubMed ID: 34113171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS).
    Toss MS; Miligy IM; Gorringe KL; AlKawaz A; Khout H; Ellis IO; Green AR; Rakha EA
    Br J Cancer; 2018 Dec; 119(12):1518-1526. PubMed ID: 30410060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal-dominant myopia associated to a novel P4HA2 missense variant and defective collagen hydroxylation.
    Napolitano F; Di Iorio V; Testa F; Tirozzi A; Reccia MG; Lombardi L; Farina O; Simonelli F; Gianfrancesco F; Di Iorio G; Melone MAB; Esposito T; Sampaolo S
    Clin Genet; 2018 May; 93(5):982-991. PubMed ID: 29364500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma.
    Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
    Scand J Gastroenterol; 2019 Jan; 54(1):95-100. PubMed ID: 30663442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer.
    Li Q; Wang Q; Zhang Q; Zhang J; Zhang J
    Am J Transl Res; 2019; 11(11):6938-6951. PubMed ID: 31814898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a homozygous P4HA2 knockout human embryonic stem cell line (FDCHDPe012-A) by CRISPR/Cas9 system.
    You J; Ma S; Zhang H; Chen L
    Stem Cell Res; 2022 Oct; 64():102930. PubMed ID: 36206672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit α members in breast cancer.
    Li M; Wang Q; Zheng Q; Wu L; Zhao B; Wu Y
    Biomark Med; 2021 Sep; 15(13):1085-1095. PubMed ID: 34387118
    [No Abstract]   [Full Text] [Related]  

  • 12. LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression.
    Zhang T; Piao HY; Guo S; Zhao Y; Wang Y; Zheng ZC; Zhang J
    Exp Mol Pathol; 2020 Oct; 116():104487. PubMed ID: 32622013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic nursing science revealed the prolyl 4-hydroxylase subunit alpha 2 as a significant biomarker involved in osteosarcoma.
    Chen HP; Han X; Sun HP; Xie T; Fan XL
    Heliyon; 2024 Mar; 10(5):e27191. PubMed ID: 38468936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition.
    Cao Y; Han Q; Li J; Jia Y; Zhang R; Shi H
    J Cancer; 2020; 11(10):2788-2799. PubMed ID: 32226497
    [No Abstract]   [Full Text] [Related]  

  • 15. Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.
    Atkinson A; Renziehausen A; Wang H; Lo Nigro C; Lattanzio L; Merlano M; Rao B; Weir L; Evans A; Matin R; Harwood C; Szlosarek P; Pickering JG; Fleming C; Sim VR; Li S; Vasta JT; Raines RT; Boniol M; Thompson A; Proby C; Crook T; Syed N
    J Invest Dermatol; 2019 May; 139(5):1118-1126. PubMed ID: 30452903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylases.
    Shi R; Gao S; Smith AH; Li H; Shao M; Shangguan J; Zhang J; Xu J; Ye J; Graham LM; Li C
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1011-1017. PubMed ID: 32819558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels.
    Grimmer C; Balbus N; Lang U; Aigner T; Cramer T; Müller L; Swoboda B; Pfander D
    Am J Pathol; 2006 Aug; 169(2):491-502. PubMed ID: 16877351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
    Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
    Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.
    Seeliger H; Pozios I; Assmann G; Zhao Y; Müller MH; Knösel T; Kreis ME; Bruns CJ
    BMC Cancer; 2018 Oct; 18(1):1049. PubMed ID: 30373552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P4HA2 involved in SLUG-associated EMT predicts poor prognosis of patients with KRAS-positive colorectal cancer.
    El-Deek HEM; El-Naggar MS; Morsy AMM; Sedik MF; Osman HA; Ahmed AM
    Med Mol Morphol; 2024 Mar; ():. PubMed ID: 38522060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.